247 related articles for article (PubMed ID: 19210158)
1. Cardiovascular disease in patients with renal disease: the role of statins.
Fellström B; Holdaas H; Jardine AG; Svensson MK; Gottlow M; Schmieder RE; Zannad F;
Curr Med Res Opin; 2009 Jan; 25(1):271-85. PubMed ID: 19210158
[TBL] [Abstract][Full Text] [Related]
2. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials.
Chan DT; Irish AB; Dogra GK; Watts GF
Atherosclerosis; 2008 Feb; 196(2):823-34. PubMed ID: 17343861
[TBL] [Abstract][Full Text] [Related]
4. The role of statins in chronic kidney disease.
Kalaitzidis RG; Elisaf MS
Am J Nephrol; 2011; 34(3):195-202. PubMed ID: 21791915
[TBL] [Abstract][Full Text] [Related]
5. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Navaneethan SD; Pansini F; Perkovic V; Manno C; Pellegrini F; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Apr; (2):CD007784. PubMed ID: 19370693
[TBL] [Abstract][Full Text] [Related]
6. Effects of statins on renal function.
Agarwal R
Mayo Clin Proc; 2007 Nov; 82(11):1381-90. PubMed ID: 17976359
[TBL] [Abstract][Full Text] [Related]
7. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
Kanbay M; Turgut F; Covic A; Goldsmith D
J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
[TBL] [Abstract][Full Text] [Related]
8. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
Scarpioni R; Ricardi M; Melfa L; Cristinelli L
Cardiovasc Ther; 2010 Dec; 28(6):361-8. PubMed ID: 20553296
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease and statins: improving cardiovascular outcomes.
Walker DB; Walker TJ; Jacobson TA
Curr Atheroscler Rep; 2009 Jul; 11(4):301-8. PubMed ID: 19500494
[TBL] [Abstract][Full Text] [Related]
10. Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era.
Heymann EP; Kassimatis TI; Goldsmith DJ
J Nephrol; 2012; 25(4):460-72. PubMed ID: 22641572
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidemia in patients with chronic kidney disease.
Hager MR; Narla AD; Tannock LR
Rev Endocr Metab Disord; 2017 Mar; 18(1):29-40. PubMed ID: 28000009
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based statin prescription for cardiovascular protection in renal impairment.
Fabbian F; De Giorgi A; Pala M; Tiseo R; Manfredini R; Portaluppi F
Clin Exp Nephrol; 2011 Aug; 15(4):456-63. PubMed ID: 21556807
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidemia in children with CKD: should we treat with statins?
Tullus K
Pediatr Nephrol; 2012 Mar; 27(3):357-62. PubMed ID: 21487766
[TBL] [Abstract][Full Text] [Related]
14. Nonstatin therapies for management of dyslipidemia: a review.
Sando KR; Knight M
Clin Ther; 2015 Oct; 37(10):2153-79. PubMed ID: 26412799
[TBL] [Abstract][Full Text] [Related]
15. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.
Hou W; Lv J; Perkovic V; Yang L; Zhao N; Jardine MJ; Cass A; Zhang H; Wang H
Eur Heart J; 2013 Jun; 34(24):1807-17. PubMed ID: 23470492
[TBL] [Abstract][Full Text] [Related]
16. Is lipid management effective for all stages of CKD?
Ku E; Campese V
Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
[TBL] [Abstract][Full Text] [Related]
17. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
18. [The interest of statins in nephrology].
Massy ZA; Andréjak M
Presse Med; 2004 Oct; 33(17):1207-12. PubMed ID: 15523292
[TBL] [Abstract][Full Text] [Related]
19. Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.
Rysz J; Gluba-Brzózka A; Banach M; Więcek A
Int Urol Nephrol; 2015 May; 47(5):805-13. PubMed ID: 25758011
[TBL] [Abstract][Full Text] [Related]
20. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
